Test Code LAB8024 Itraconazole, Serum
Additional Codes
ITCON
Useful For
Verifying systemic absorption of orally administered itraconazole
Patients with life-threatening fungal infections
Patients considered at risk for poor absorption or rapid clearance of itraconazole
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
Serum RedSpecimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial within 2 hours of collection.
Specimen Minimum Volume
0.18 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 29 days | |
Ambient | 29 days | ||
Frozen | 29 days |
On-campus collections: Tube to 99 or deliver to University Extension Hospital Room EH31
Send in plastic vial, Refrigerated.
Off-campus collections: Centrifuge and aliquot within 2 hours. Specimen to be stored/transported at Refrigerated temp.
Reference Values
ITRACONAZOLE (TROUGH):
>0.5 mcg/mL (localized infection)
>1 mcg/mL (systemic infection)
HYDROXYITRACONAZOLE:
No therapeutic range established; activity and serum concentration are similar to parent drug.
Day(s) Performed
Monday through Friday; Saturday
CPT Code Information
80189
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ITCON | Itraconazole, S | 10989-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
81247 | Itraconazole, S | 10989-2 |
5122 | Hydroxyitraconazole | 18337-6 |
Interpretation
A lower cutoff concentration has not been defined that applies in all cases. The serum concentration must be interpreted in association with other variables, such as the nature of the infection, the specific microorganism, and minimal inhibitory concentration results, if available. Localized infections are more likely to respond when serum itraconazole is more than 0.5 mcg/mL (by high-performance liquid chromatography); systemic infections generally require drug concentrations more than 1.0 mcg/mL. Consider target of more than 1.5 mcg/mL for itraconazole plus hydroxyitraconazole. Therapeutic drug monitoring should be done at steady state, which usually occurs in about 7 days. Timing of the serum collection is not as critical due to the drug's long half-life, but trough collections are recommended.
Method Description
Itraconazole and hydroxyitraconazole are extracted by mixing serum samples with acetonitrile to precipitate proteins. The supernatant is removed and analyzed by an in-house developed liquid chromatography-tandem mass spectrometry method.(Unpublished Mayo method)
Report Available
1 to 3 daysSpecimen Retention Time
2 weeksReject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Secondary ID
81247Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.